Related Experiment Video
Updated: Aug 11, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Recent developments in the therapy of acromegaly
Angela N Paisley1, Peter J Trainer
1Department of Endocrinology, Christie Hospital, Manchester, M20 4BX, UK.
Expert Opinion on Investigational Drugs
|March 1, 2006
Summary
Acromegaly, caused by excess growth hormone, significantly impacts health. Effective disease control normalizes life expectancy and reduces symptoms, with a focus on emerging medical treatments.
Area of Science:
- Endocrinology
- Oncology
- Neurosurgery
Background:
- Acromegaly results from growth hormone hypersecretion, often from pituitary tumors.
- This condition leads to increased morbidity and mortality if left untreated.
- Controlling acromegaly normalizes life expectancy and alleviates symptoms.
Purpose of the Study:
- To review emerging concepts in the medical management of acromegaly.
- To highlight advancements beyond traditional treatments like surgery and radiotherapy.
Main Methods:
- Literature review of recent studies on acromegaly treatment.
- Analysis of emerging pharmacological and therapeutic strategies.
- Synthesis of current evidence on medical interventions.
Main Results:
- Surgery is primary but often insufficient for macroadenomas, necessitating medical therapy.
- Medical management plays a crucial role in achieving disease control for many patients.
- Emerging treatments offer new hope for managing acromegaly effectively.
Conclusions:
- Medical management is essential for comprehensive acromegaly treatment, especially for macroadenomas.
- Advancements in medical therapies are improving outcomes and quality of life.
- Further research into novel treatments is ongoing.
